Literature DB >> 21680512

Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses.

Shin-Hee Kim1, Madhuri Subbiah, Arthur S Samuel, Peter L Collins, Siba K Samal.   

Abstract

Virulent and moderately virulent strains of Newcastle disease virus (NDV), representing avian paramyxovirus serotype 1 (APMV-1), cause respiratory and neurological disease in chickens and other species of birds. In contrast, APMV-2 is avirulent in chickens. We investigated the role of the fusion (F) and hemagglutinin-neuraminidase (HN) envelope glycoproteins in these contrasting phenotypes by designing chimeric viruses in which the F and HN glycoproteins or their ectodomains were exchanged individually or together between the moderately virulent, neurotropic NDV strain Beaudette C (BC) and the avirulent APMV-2 strain Yucaipa. When we attempted to exchange the complete F and HN glycoproteins individually and together between the two viruses, the only construct that could be recovered was recombinant APMV-2 strain Yucaipa (rAPMV-2), containing the NDV F glycoprotein in place of its own. This substitution of NDV F into APMV-2 was sufficient to confer the neurotropic, neuroinvasive, and neurovirulent phenotypes, in spite of all being at reduced levels compared to what was seen for NDV-BC. When the ectodomains of F and HN were exchanged individually and together, two constructs could be recovered: NDV, containing both the F and HN ectodomains of APMV-2; and APMV-2, containing both ectodomains of NDV. This supported the idea that homologous cytoplasmic tails and matched F and HN ectodomains are important for virus replication. Analysis of these viruses for replication in vitro, syncytium formation, mean embryo death time, intracerebral pathogenicity index, and replication and tropism in 1-day-old chicks and 2-week-old chickens showed that the two contrasting phenotypes of NDV and APMV-2 could largely be transferred between the two backbones by transfer of homotypic F and HN ectodomains. Further analysis provided evidence that the homologous stalk domain of NDV HN is essential for virus replication, while the globular head domain of NDV HN could be replaced with that of APMV-2 with only a minimal attenuating effect. These results demonstrate that the F and HN ectodomains together determine the cell fusion, tropism, and virulence phenotypes of NDV and APMV-2 and that the regions of HN that are critical to replication and the species-specific phenotypes include the cytoplasmic tail and stalk domain but not the globular head domain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680512      PMCID: PMC3165810          DOI: 10.1128/JVI.00652-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Hemagglutinin-neuraminidase (HN) amino acid alterations in neutralization escape mutants of Kilham mumps virus.

Authors:  J Kövamees; R Rydbeck; C Orvell; E Norrby
Journal:  Virus Res       Date:  1990-10       Impact factor: 3.303

2.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

3.  Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.

Authors:  B Dietzschold; T J Wiktor; J Q Trojanowski; R I Macfarlan; W H Wunner; M J Torres-Anjel; H Koprowski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

4.  Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo.

Authors:  M N Teng; S S Whitehead; P L Collins
Journal:  Virology       Date:  2001-10-25       Impact factor: 3.616

5.  Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutinin-neuraminidase and fusion proteins.

Authors:  M B Stope; A Karger; U Schmidt; U J Buchholz
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Interacting domains of the HN and F proteins of newcastle disease virus.

Authors:  Kathryn A Gravel; Trudy G Morrison
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Isolation of the nucleic acid of Newcastle disease virus (NDV).

Authors:  P H Duesberg; W S Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1965-09       Impact factor: 11.205

8.  Phylogenetic relationships among virulent Newcastle disease virus isolates from the 2002-2003 outbreak in California and other recent outbreaks in North America.

Authors:  Janice C Pedersen; Dennis A Senne; Peter R Woolcock; Hailu Kinde; Daniel J King; Mark G Wise; Brundaban Panigrahy; Bruce S Seal
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence.

Authors:  Zhuhui Huang; Aruna Panda; Subbiah Elankumaran; Dhanasekaran Govindarajan; Daniel D Rockemann; Siba K Samal
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

10.  Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice.

Authors:  M Matloubian; T Somasundaram; S R Kolhekar; R Selvakumar; R Ahmed
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

View more
  28 in total

1.  Complete genome sequence of a novel avian paramyxovirus.

Authors:  François-Xavier Briand; Aurélie Henry; Pascale Massin; Véronique Jestin
Journal:  J Virol       Date:  2012-07       Impact factor: 5.103

2.  Evaluation of the contributions of individual viral genes to newcastle disease virus virulence and pathogenesis.

Authors:  Anandan Paldurai; Shin-Hee Kim; Baibaswata Nayak; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

3.  Activation of the extracellular signal-regulated kinase pathway is required for replication of Newcastle disease virus.

Authors:  Jie Ni; Shunlin Hu; Xiaoquan Wang; Xiaowen Liu; Zenglei Hu; Xiufan Liu
Journal:  Arch Virol       Date:  2021-01-24       Impact factor: 2.574

Review 4.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.

Authors:  Dmitriy Zamarin; Peter Palese
Journal:  Future Microbiol       Date:  2012-03       Impact factor: 3.165

5.  Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducks.

Authors:  Shin-Hee Kim; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

Review 6.  Oncolytic virus therapy for cancer.

Authors:  Joe Goldufsky; Shanthi Sivendran; Sara Harcharik; Michael Pan; Sebastian Bernardo; Richard H Stern; Philip Friedlander; Carl E Ruby; Yvonne Saenger; Howard L Kaufman
Journal:  Oncolytic Virother       Date:  2013-09-23

7.  Synthesis and chemical characterization of several perfluorinated sialic acid glycals and evaluation of their in vitro antiviral activity against Newcastle disease virus.

Authors:  P Rota; N Papini; P La Rocca; M Montefiori; F Cirillo; M Piccoli; R Scurati; L Olsen; P Allevi; L Anastasia
Journal:  Medchemcomm       Date:  2017-06-05       Impact factor: 3.597

8.  Virulence of Newcastle disease virus: what is known so far?

Authors:  Jos C F M Dortmans; Guus Koch; Peter J M Rottier; Ben P H Peeters
Journal:  Vet Res       Date:  2011-12-23       Impact factor: 3.683

9.  Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 4 confer increased replication and syncytium formation in vitro but not increased replication and pathogenicity in chickens and ducks.

Authors:  Shin-Hee Kim; Sa Xiao; Heather Shive; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Effects of the HN gene C-terminal extensions on the Newcastle disease virus virulence.

Authors:  Wei Zhao; Zhenyu Zhang; Laszlo Zsak; Qingzhong Yu
Journal:  Virus Genes       Date:  2013-09-14       Impact factor: 2.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.